Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

28 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Level of Notch activation determines the effect on growth and stem cell-like features in glioblastoma multiforme neurosphere cultures.
Kristoffersen K, Villingshøj M, Poulsen HS, Stockhausen MT. Kristoffersen K, et al. Among authors: stockhausen mt. Cancer Biol Ther. 2013 Jul;14(7):625-37. doi: 10.4161/cbt.24595. Epub 2013 May 10. Cancer Biol Ther. 2013. PMID: 23792644 Free PMC article.
Combined EGFR- and notch inhibition display additive inhibitory effect on glioblastoma cell viability and glioblastoma-induced endothelial cell sprouting in vitro.
Staberg M, Michaelsen SR, Olsen LS, Nedergaard MK, Villingshøj M, Stockhausen MT, Hamerlik P, Poulsen HS. Staberg M, et al. Among authors: stockhausen mt. Cancer Cell Int. 2016 Apr 26;16:34. doi: 10.1186/s12935-016-0309-2. eCollection 2016. Cancer Cell Int. 2016. PMID: 27118928 Free PMC article.
18F-FET microPET and microMRI for anti-VEGF and anti-PlGF response assessment in an orthotopic murine model of human glioblastoma.
Nedergaard MK, Michaelsen SR, Urup T, Broholm H, El Ali H, Poulsen HS, Stockhausen MT, Kjaer A, Lassen U. Nedergaard MK, et al. Among authors: stockhausen mt. PLoS One. 2015 Feb 13;10(2):e0115315. doi: 10.1371/journal.pone.0115315. eCollection 2015. PLoS One. 2015. PMID: 25680186 Free PMC article.
Inhibition of Notch signaling alters the phenotype of orthotopic tumors formed from glioblastoma multiforme neurosphere cells but does not hamper intracranial tumor growth regardless of endogene Notch pathway signature.
Kristoffersen K, Nedergaard MK, Villingshøj M, Borup R, Broholm H, Kjær A, Poulsen HS, Stockhausen MT. Kristoffersen K, et al. Among authors: stockhausen mt. Cancer Biol Ther. 2014 Jul;15(7):862-77. doi: 10.4161/cbt.28876. Epub 2014 Apr 22. Cancer Biol Ther. 2014. PMID: 24755988 Free PMC article.
Differentiation of glioblastoma multiforme stem-like cells leads to downregulation of EGFR and EGFRvIII and decreased tumorigenic and stem-like cell potential.
Stockhausen MT, Kristoffersen K, Stobbe L, Poulsen HS. Stockhausen MT, et al. Cancer Biol Ther. 2014 Feb;15(2):216-24. doi: 10.4161/cbt.26736. Epub 2013 Nov 1. Cancer Biol Ther. 2014. PMID: 24525857 Free PMC article.
Clinical variables serve as prognostic factors in a model for survival from glioblastoma multiforme: an observational study of a cohort of consecutive non-selected patients from a single institution.
Michaelsen SR, Christensen IJ, Grunnet K, Stockhausen MT, Broholm H, Kosteljanetz M, Poulsen HS. Michaelsen SR, et al. Among authors: stockhausen mt. BMC Cancer. 2013 Sep 3;13:402. doi: 10.1186/1471-2407-13-402. BMC Cancer. 2013. PMID: 24004722 Free PMC article.
Notch signaling and brain tumors.
Stockhausen MT, Kristoffersen K, Poulsen HS. Stockhausen MT, et al. Adv Exp Med Biol. 2012;727:289-304. doi: 10.1007/978-1-4614-0899-4_22. Adv Exp Med Biol. 2012. PMID: 22399356 Review.
Prospective evaluation of angiogenic, hypoxic and EGFR-related biomarkers in recurrent glioblastoma multiforme treated with cetuximab, bevacizumab and irinotecan.
Hasselbalch B, Eriksen JG, Broholm H, Christensen IJ, Grunnet K, Horsman MR, Poulsen HS, Stockhausen MT, Lassen U. Hasselbalch B, et al. Among authors: stockhausen mt. APMIS. 2010 Aug;118(8):585-94. doi: 10.1111/j.1600-0463.2010.02631.x. APMIS. 2010. PMID: 20666740
Cetuximab insufficiently inhibits glioma cell growth due to persistent EGFR downstream signaling.
Hasselbalch B, Lassen U, Poulsen HS, Stockhausen MT. Hasselbalch B, et al. Among authors: stockhausen mt. Cancer Invest. 2010 Oct;28(8):775-87. doi: 10.3109/07357907.2010.483506. Cancer Invest. 2010. PMID: 20504227
Cetuximab, bevacizumab, and irinotecan for patients with primary glioblastoma and progression after radiation therapy and temozolomide: a phase II trial.
Hasselbalch B, Lassen U, Hansen S, Holmberg M, Sørensen M, Kosteljanetz M, Broholm H, Stockhausen MT, Poulsen HS. Hasselbalch B, et al. Among authors: stockhausen mt. Neuro Oncol. 2010 May;12(5):508-16. doi: 10.1093/neuonc/nop063. Epub 2010 Feb 5. Neuro Oncol. 2010. PMID: 20406901 Free PMC article. Clinical Trial.
28 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback